NCT07297862

Brief Summary

The aim of this study is to examine the effects of virtual reality on physiological factors (heart rate, blood pressure) in stroke patients and the psychometric properties of the Virtual Reality Sickness Questionnaire in assessing Motion Sickness resulting from virtual reality use.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
3mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Jul 2025Aug 2026

Study Start

First participant enrolled

July 16, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 19, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 22, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2026

Last Updated

March 25, 2026

Status Verified

March 1, 2026

Enrollment Period

1 year

First QC Date

November 19, 2025

Last Update Submit

March 24, 2026

Conditions

Keywords

Motion SicknessVirtual Reality Sickness QuestionnairePsychometric PropertiesStroke

Outcome Measures

Primary Outcomes (1)

  • Virtual Reality Sickness Questionnaire

    The Virtual Reality Sickness Questionnaire (VRSQ), which consists of 9 items and two main headings: oculomotor discomfort and disorientation, will be used to assess Motion Sickness symptoms. The items will be scored between 0-3. As a result of VRSQ oculomotor, disorientation and total scores will be obtained. Oculomotor and disorientation scores will be calculated by dividing the individual's component score by the total score obtained (as a percentage). Minimum score is 0 and maximum score is 100. Higher scores mean more symptoms.

    immediately after roller coaster application

Secondary Outcomes (8)

  • Titmus Test

    Baseline

  • National Institutes of Health Stroke Scale (NIHSS)

    Baseline

  • Standardized Mini Mental Test (SMMT)

    Baseline

  • The Motion Sensitivity Test (MST)

    immediately after roller coaster application

  • Tolerance Period

    During application

  • +3 more secondary outcomes

Study Arms (2)

Stroke Group

Other: Roller Coaster application

Healthy Group

Other: Roller Coaster application

Interventions

Participants will experience a 15-minute roller coaster virtual reality (VR) for three consecutive days, once a day. During this study, the virtual reality application will be performed while sitting in a chair and while fixed to the chair. The practitioner will be present with the participant throughout the VR application.

Healthy GroupStroke Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This prospective study will be conducted in BAIBU Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation on healthy individuals and individuals with stroke who agree to participate in the study. Individuals between the ages of 18-80 will be included in the study. Individuals will be asked to experience VR for 15 minutes and then fill out the Virtual Reality Sickness Questionnaire. Individuals whose score in this questionnaire is not 10 and above will be excluded from the study. Individuals who meet the inclusion criteria will be divided into two groups as healthy and stroke patients after demographic information is obtained.

You may qualify if:

  • Stroke diagnosis,
  • A minimum score of 24 on the Standardised Mini Mental Test (SMMT), 2.18-80 years old,
  • showing symptoms of MS with a minimum score of 10 on the Virtual Reality Sickness Questionnaire
  • Titmus test result of 3552 arc/s
  • Not having neglect syndrome

You may not qualify if:

  • Not volunteering for the study,
  • Presence of a diagnosis of neurological disease other than stroke,
  • Presence of a history of previous stroke,
  • Complete or partial loss of vision in one eye,
  • Previous use of Virtual Reality
  • Having diseases affecting the vestibular system such as Vertigo, Benign Paroxysmal Vertigo, Meniere's
  • \. A minimum score of 24 on the Standardised Mini Mental Test (SMMT), 2.18-80 years old, 3. showing symptoms of MS with a minimum score of 10 on the Virtual Reality Sickness Questionnaire 4. Titmus test result of 3552 arc/s
  • Not volunteering for the study,
  • Presence of a diagnosis of neurological disease,
  • Complete or partial loss of vision in one eye,
  • Previous use of Virtual Reality
  • Having diseases affecting the vestibular system such as Vertigo, Benign Paroxysmal Vertigo, Meniere's

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abant Izzet Baysal University

Bolu, 14300, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Motion SicknessStroke

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

November 19, 2025

First Posted

December 22, 2025

Study Start

July 16, 2025

Primary Completion (Estimated)

July 16, 2026

Study Completion (Estimated)

August 16, 2026

Last Updated

March 25, 2026

Record last verified: 2026-03

Locations